(Q35017766)

5 August 2017

1 reference

title

Global epidemiology and burden of hepatitis C. (English)

1 reference

5 August 2017

1 reference

W Ray Kim

1

1 reference

5 August 2017

1 October 2002

1 reference

5 August 2017

Microbes and Infection

1 reference

5 August 2017

4

1 reference

5 August 2017

1219-1225

1 reference

5 August 2017

12

1 reference

Hepatitis C virus infection

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Patient-to-patient transmission of hepatitis C virus during colonoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

The prevalence of hepatitis C virus antibodies among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Calculating the global burden of disease: time for a strategic reappraisal?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

The global burden of disease, 1990–2020

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

Outcome of hospital care of liver disease associated with hepatitis C in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901649-0

7 January 2021

10.1016/S1286-4579(02)01649-0

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12467763